Bioporto AS (LTS:0JJM) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JJM Bioporto AS LTS:0JJM
70 GF Score
Price kr1.22
GF Value kr1.33
! 4 Warning Signs
View Full Analysis

What is Bioporto AS FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0JJM
70GF Score
Bioporto AS LTS:0JJM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioporto AS (LTS:0JJM) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of kr1.22 is trading 8.1% below its estimated GF Value™ of kr1.33.

Key valuation signals for LTS:0JJM:

  • FFO:
  • GF Value™: kr1.33 vs. price of kr1.22 (8.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the LTS:0JJM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioporto AS Business Description

Other Exchanges BIOPOR:Denmark
Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
70GF Score

Get the complete analysis for LTS:0JJM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.22
Price
kr1.33
GF Value